What Jolly Good does

Jolly Good (ジョリーグッド / Jolly Good Inc.) is a Tokyo-based private company founded in 2014 by CEO Kensuke Joji that builds VR-based medical education, digital therapeutics, and spatial AI analytics. Its flagship platform JOLLYGOOD+ distributes 600+ proprietary 360° VR titles across medical, nursing, welfare, and industrial safety use cases via subscription, with a Pro Plan priced at ¥3,300/month and enterprise tiers sold by quote. Its digital therapeutics brand FACE DUO (also styled VRDTx) delivers CBT-based VR therapy for depression and social anxiety, reporting a 69.2% remission rate and protected by a granted Japan-US patent on AI-personalized video optimization. The proprietary VRCHEL engine, repositioned in December 2025 as the Multimodal AI Lab, performs 360° spatial recognition and behavioral/gaze analysis on approximately 800 real-world data pieces and is exposed to partners via API.

The company monetizes through a mix of recurring subscriptions (JOLLYGOOD+), licensing/royalties on digital therapeutics and patents (notably an exclusive co-development and sales arrangement with Otsuka Pharmaceutical in Japan worth up to ¥5 billion, including a ¥300 million upfront payment), usage-based AI analysis services via VRCHEL, and professional services for custom content and the JG Robot Ready robotics adoption solution launched in 2026. Distribution combines direct enterprise sales, co-marketing with pharmaceutical partners Otsuka and Teijin, channel partnerships with healthcare network CareAbout Health, academic adoption at Harvard Medical School, Brigham and Women's Hospital, George Mason University, and Mahidol University, and marketplace listings on Apple Vision Pro and Meta Quest. Jolly Good raised approximately ¥2.2 billion (~$22M USD) across disclosed rounds through 2021, operates a wholly-owned North American subsidiary (Jolly Good US Inc., Brookline, MA, established 2023), and holds ISMS certification for information security. The company has begun expanding beyond healthcare into construction/manufacturing safety VR, government grant AI matching (KOUBO NEXT, 2026), and robot adoption support (JG Robot Ready, 2026).

Name

Jolly Good

Legal name

株式会社ジョ리그ッド (Jolly Good Inc.)

Website

https://jollygood.co.jp

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

1–10 employees

Short description

Jolly Good is a Japanese VR healthcare company providing immersive medical education (JOLLYGOOD+), AI-powered digital therapeutics (FACE DUO) for depression and anxiety, and spatial AI analytics (VRCHEL) to 200+ medical institutions, universities, and pharmaceutical partners across Japan, the US, and Thailand.

Ownership category

akta.pro rank

Product category

VR Medical Education and Digital Therapeutics Software

NAICS

Software Publishers (5132), Health Care and Social Assistance (62)

SIC

Services-Health Services (8000)

akta.pro primary industry

Behavioral Health & Neurocognitive Therapeutics (Digital) (HLACANAI)

akta.pro secondary industries

Healthcare & Clinical Simulation (Surgery, Nursing, EMT, Patient Interaction) (EDAFAJAC), Therapeutic Companion Apps (Drug-Device-Digital Combination) (HLACANAH)

Keywords

• VR medical education
• Digital therapeutics
• 360-degree VR training
• Spatial AI analytics
• VR safety training

Headquarters

HQ city

Tokyo

HQ country

Japan

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

1. JOLLYGOOD+ Subscription: Monthly and annual subscription access to the VR content library and platform, with tiered plans for individual, institutional, and enterprise users.
2. Digital Therapeutics Licensing (FACE DUO): Licensing of FACE DUO DTx platform to healthcare providers and pharmaceutical partners for clinical deployment in mental health treatment programs.
3. AI Analysis Services (VRCHEL): Usage-based AI-powered spatial analysis services for research institutions and enterprise clients analyzing behavioral data from VR training scenarios.
4. Patent Licensing: Licensing of proprietary patents covering personalized treatment video systems and AI learning guide auto-generation to third parties.
5. Robot Implementation Services (JG Robot Ready): Professional services for robotics deployment and integration support in healthcare settings.
6. Custom Content Development: Professional services for developing bespoke VR training content tailored to specific medical, corporate, or institutional requirements.

Pricing tiers

Go-to-market motion4 records

Distribution channels5 records

Marketing channels5 records

Core offering

Jolly Good develops and sells a VR-based medical education and digital therapeutics platform centered on 360-degree immersive video and proprietary AI analysis. Its flagship JOLLYGOOD+ platform offers 600+ VR content titles for clinical training, nursing care, and corporate safety, while the FACE DUO digital therapeutics line delivers CBT-based VR treatment for depression and social anxiety. The company also licenses VRCHEL spatial AI technology and provides robot adoption support via JG Robot Ready.

Product overview

Jolly Good is a platform-plus-modules company offering VR-based healthcare education and digital therapeutics solutions. The core platform JOLLYGOOD+ provides 600+ VR content titles for healthcare, welfare, and industry training via subscription. FACE DUO delivers next-generation digital therapeutics combining CBT-based VR with AI-powered personalized treatment. VRCHEL/Multimodal AI Lab serves as the proprietary AI engine processing 360° video for spatial analysis and learning optimization. JG Robot Ready extends the platform to robot adoption support using 360° VR and AI. KOUBO NEXT provides AI-powered public grant matching. The products share a common foundation of 360° VR technology and proprietary AI systems (VRCHEL, Mental & Physical State Optimization AI) protected by Japan-US patents. Integration across devices includes VR goggles, smartphones, tablets, and Apple Vision Pro.

Differentiator

Problem solved

Functional benefit

Brands

• JOLLYGOOD+: 360° VR education platform specializing in healthcare, welfare, and industry with 600+ VR content titles available via monthly subscription
• FACE DUO / VRDTx
• VRCHEL
• JG Robot Ready
• Multimodal AI Lab
• VR Dementia Education Course

Products and services

• JOLLYGOOD+ 360-degree VR education platform specializing in healthcare, welfare, and industry. Provides 600+ VR content titles for medical education, nursing care, social skills training, and safety via monthly subscription accessible on VR headsets, smartphones, and tablets.
• FACE DUO Next-generation digital therapeutics platform powered by VR and AI. Combines CBT-based VR therapy with face-to-face healthcare for depression and social anxiety. Includes an AI personalization system that optimizes video content based on patient biometric data.
• VRCHEL / Multimodal AI Lab Proprietary 360-degree spatial analysis AI system that converts on-site tacit knowledge into AI training data. Integrates image, audio, behavior, and gaze analysis with API access for partners.
• JG Robot Ready Total support service for robot adoption in healthcare and industrial settings. Provides AI-powered environment diagnosis, safety education VR with collision experience training, and skilled skill digital inheritance.
• KOUBO NEXT AI-powered platform for automatic matching of public grants and subsidies to enterprises. Provides DX solution packages for logistics, manufacturing, medical robot adoption, university/medical institution education, and high school DX education.
• emou Social skills training VR program for individuals with developmental disabilities, introduced to more than 100 facilities across Japan. Developed using expertise from disability welfare support.
• VR Dementia Education Course George Mason University-supervised VR course addressing the 53% annual turnover rate in US long-term care facilities through dementia education.
• Palliative Care Communication Training VR First US palliative care communication training VR, developed in collaboration with Brigham and Women's Hospital. Reduces palliative care education from 4 hours to 1 hour.
• Frailty Prevention Support VR (FACEDUO) VR training content for frailty prevention within Otsuka Pharmaceutical's FACEDUO program. Enables users to experience early signs of frailty through VR simulations, focusing on nutrition, physical activity, and social participation.
• JOLLYGOOD+ for Vision Pro Spatial computing healthcare service built natively for Apple Vision Pro, providing immersive medical training and healthcare services beyond conventional VR limitations.

Quantifiable outcome

• Depression remission rate of 69.2% using FACE DUO digital therapeutics platform
• +4 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

AI capability11 records

Feature5 records

Partnerships

Nine partnerships are on record, tiered flagship, core and minor.

• Otsuka PharmaceuticalflagshipGTM or Marketing PartnerStrategic partnership for co-promotion and distribution of FACE DUO digital therapeutics platform for mental health treatment through Otsuka's pharmaceutical distribution network and healthcare provider relationships in Japan.
• Teijin PharmacoreGTM or Marketing PartnerPartnership for digital therapeutics collaboration, leveraging Teijin Pharma's healthcare network to expand distribution of VR-based treatment solutions.
• Harvard Medical SchoolflagshipStrategic or Co-development PartnerResearch collaboration on VR medical education, including spatial learning effectiveness studies and development of validated VR training curricula for clinical procedures.
• Brigham and Women's HospitalflagshipStrategic or Co-development PartnerClinical research partnership for VR-based medical training programs, leveraging the hospital's clinical expertise to validate VR training effectiveness.
• George Mason UniversitycoreStrategic or Co-development PartnerAcademic partnership for VR medical education curriculum integration, including research demonstrating 135% increase in neurosurgery student interest and 2.05x improvement in team collaboration.
• Mahidol UniversitycoreStrategic or Co-development PartnerInternational academic partnership in Thailand for VR medical education deployment and collaborative research on VR training effectiveness in Asian healthcare contexts.
• Apple Vision ProcoreTechnology or IntegrationNative platform integration enabling JOLLYGOOD+ VR content library on Apple Vision Pro, providing immersive training experiences through Apple's spatial computing platform.
• Meta QuestcoreTechnology or IntegrationPlatform integration for JOLLYGOOD+ content distribution on Meta Quest VR headsets, enabling broad access to VR training content through Meta's consumer and enterprise VR ecosystem.
• CareAbout HealthminorChannel Partner/ Reseller/ DistributorHealthcare channel partnership for distributing VR training and digital therapeutics solutions through CareAbout Health's network of healthcare providers and corporate clients.

Scale indicators9 records

Recent moves10 records

Expansion highlights6 records

Direct peers

• Osso VR: Osso VR provides VR-based surgical and medical procedure training for healthcare professionals and medical device companies. It is the closest direct peer to Jolly Good's JOLLYGOOD+ clinical simulation and procedure training business.
• AppliedVR: AppliedVR develops FDA-authorized VR-based digital therapeutics, including for chronic pain. It directly mirrors Jolly Good's FACE DUO strategy of combining immersive VR with clinical evidence and prescription-grade positioning.
• FundamentalVR: FundamentalVR delivers VR surgical training with haptic feedback (similar to Jolly Good's Skill Sensation Synchronization patent). It competes in the same medical VR training category with global hospital and medical school customers.
• BehaVR: BehaVR builds VR-based digital therapeutics for mental and behavioral health (anxiety, depression, chronic pain). It overlaps directly with FACE DUO's CBT-based VR therapy positioning and pharma co-development model.
• XRHealth: XRHealth operates a VR telehealth platform pairing immersive therapy with licensed clinicians. It is comparable to Jolly Good's combination of VR content library with clinical deployment and prescription-style delivery.
• Surgical Theater: Surgical Theater provides VR surgical planning and training for hospitals and medical schools. It overlaps with Jolly Good's JOLLYGOOD+ medical education use cases for surgical preparation and clinical simulation.
• ImmersiveTouch: ImmersiveTouch provides VR-based surgical simulation and training with analytics, comparable to Jolly Good's JOLLYGOOD+ procedure training and VRCHEL behavior-and-gaze analytics for medical education customers.

Broad incumbents

• MindMaze: MindMaze is a larger neuro-rehabilitation and digital therapeutics company using VR/AI across stroke recovery, cognition, and communication. It overlaps with Jolly Good's DTx and clinical VR content but operates at significantly greater scale and capital base.
• Penumbra (Real Immersive): Penumbra's Real Immersive system delivers VR rehabilitation therapy for upper extremities in clinical settings. As a public medical device incumbent, it competes with Jolly Good's rehabilitation-adjacent VR therapy content but with broader hardware and reimbursement reach.

Emerging players

• Karuna Labs: Karuna Labs builds VR-based chronic pain and rehabilitation programs with clinically validated outcomes. It is an emerging player in the same VR digital therapeutics category where Jolly Good is developing chronic-pain CBT content with Boston University.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/jollygood_press
• YouTubeyoutube.com/channel/UCTgJ_7RLVCCpbkGOr-fMfEw
• Facebookfacebook.com/jollygoodinc
• LinkedInlinkedin.com/company/jollygood-inc
• Instagraminstagram.com/jollygood_press

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries1 record

Funding overview

Funding rounds5 records

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Jolly Good